Study identifies promising biomarker for early sepsis detection in neonates, children and pregnant women

A study presented at ESCMID Global 2025 has uncovered the potential of interleukin-6 (IL-6) as a powerful diagnostic biomarker for the early detection of sepsis in high-risk patient groups, including neonates, children and pregnant women. This study is the first to evaluate IL-6's diagnostic performance in a real-world cohort across all three populations.
š Full Story

Boat Cruise Turned Into a Full-Blown Fight in Florida Waters!
- Espresso 15 Pro review: Just a really nice (though pricey) portable monitor - Sam Rutherford
- UK on alert after H5N1 bird flu spills over to sheep in world-first - Beth Mole
- How The Star Wars Sequels Doomed Disney+ - Chris Snellgrove
- How Much Down Payment Is Required for a House?
- YRKKH Written Update 11 August 2024: Abhira Refuses to Marry Arman as Ruhiās Plan Unfolds! - Aaradhana Chaurasia
- Blue Originās all-female crew, including Katy Perry, successfully launched - Lauren Forristal

2000 vs 30000 INR Smart Glasses!
- Poolhouse raises $34M for gamified pool from the creators of Topgolf - Dean Takahashi
- Scalable technique for single-cell sequencing enhances drug screening research
- Conifer locks down $20M seed round for its ādrop-inā electric hub motor - Sean O'Kane
- This AI already writes 20% of Salesforceās code. Hereās why developers arenāt worried - Michael NuƱez
- Does a Humidifier Help With Allergies? - Lindsay Curtis
- Understanding and Managing Duck-Footedness: A Comprehensive Guide - Mark Gurarie